Clinical Trial Detail

NCT ID NCT04318717
Title Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

mucosal melanoma

Therapies

Pembrolizumab

Age Groups: child adult senior

No variant requirements are available.